Related Experiment Video
Updated: Mar 16, 2026

12:33
High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
Published on: November 15, 2013
48.7K
[Not Available]
1Services de pathologie morphologique et moléculaire, Département de biologie et pathologie médicales; AMMICa, Inserm US23/CNRS UMS3655, Gustave Roussy Cancer Campus, 114, rue Edouard Vaillant, 94805 Villejuif cedex, France..
Bulletin Du Cancer
|August 7, 2016
Summary
Pathology remains essential for evaluating metastatic disease. Advanced molecular techniques analyze tumor cells and their microenvironment, providing comprehensive phenogenomic characterization for personalized cancer care.
Area of Science:
- Oncology
- Molecular Pathology
- Genomics
Background:
- Metastatic disease evaluation increasingly utilizes molecular techniques.
- Traditional methods are complemented by advanced molecular analyses.
Purpose of the Study:
- To highlight the indispensable role of pathology in metastatic disease evaluation.
- To underscore the importance of integrated molecular analysis of tumors and their microenvironment.
Main Methods:
- In situ molecular techniques: immunohistochemistry, in situ hybridization, and fluorescence in situ hybridization (FISH).
- Molecular biology techniques applied to both frozen and fixed tissue samples.
- Analysis of tumor cells and their surrounding stroma, including immune cells.
Main Results:
- Integrated molecular approaches correlate genomic alterations with functional and structural changes.
- Tumor microenvironment analysis yields crucial prognostic and predictive biomarkers.
- Phenogenomic characterization of tumors as organs is achievable through comprehensive tissue analysis.
Conclusions:
- Pathology is mandatory for a complete understanding of metastatic disease.
- The integration of molecular techniques and microenvironment analysis is vital for advancing cancer diagnostics and therapeutics.
- Tissue analysis enables a shift from descriptive to functional genomics and integrated biology in oncology.

